The hedge fund increased its position in STAAR Surgical by 1.1 million shares, lifting its stake to 21.25% of reportable AUM.
Broadwood Capital purchased 1,104,351 shares of STAAR Surgical (NASDAQ:STAA) in the first quarter, a $21.08 million transaction based on the quarter’s average share price. The move raised its stake to 21.25% of the fund’s reportable assets under management as of March 31, 2026.
Despite the purchase, the fund’s quarter-end position in STAAR Surgical declined in value by $45.28 million, reflecting stock price fluctuations. STAAR Surgical’s shares traded at $32.01 on May 14, 2026, up 83.6% over the past year and outperforming the S&P 500 by 56.35 percentage points.
STAAR Surgical remains Broadwood Capital’s second-largest holding, valued at $301.52 million, trailing only Monster Beverage (NASDAQ:MNST) at $587.49 million. The fund’s other top positions include Axon Enterprise and iShares Russell 2000 ETF.